tVNS Applications in Patients in Coma Discussed in Poland
2 days ago
2 min read
Nervovita Medical Technologies participated in the Polish Coma Symposium, which focused on tVNS applications in patients in coma and opportunities for future scientific research.
Nervovita Medical Technologies participated in the Polish Coma Symposium, which focused on tVNS applications in patients in coma and opportunities for future scientific research.
Transcutaneous vagus nerve stimulation in patients in coma has been an ongoing area of research, with contributions from scientists across several countries. Held on 14–15 November 2024, the symposium provided a platform to review clinical experience in this field and discuss potential future studies.
Led by the Akogo Foundation, the symposium brought together Prof. Halil Özcan, Head of the Department of Psychiatry at Atatürk University; Prof. Arshad Majid from the University of Sheffield; Prof. Armin Bolz, developer of the tVNS® device; and Selin Erdoğan Gezen, Founder of Nervovita Medical Technologies and Global Clinical Director at tVNS Health.
Hosted by the “Alarm Clock” coma clinics, which serve paediatric and adult patients, the meeting featured clinical experiences with tVNS applications in patients in coma across different countries. Experts discussed patient groups in which tVNS could be investigated, current application approaches, and potential future research.
The symposium also included case presentations from Assoc. Prof. Burcu Polat and Prof. Ercan Gürses of Türkiye, describing treatments they had administered to patients with hypoxic injury. These presentations provided a valuable basis for scientific discussion on future research and treatment protocols.
Attracting interest from the media and scientific and clinical communities, the event offered a productive forum for assessing the research potential of tVNS in patients in coma and advancing international scientific collaboration.
At Nervovita Medical Technologies, we continue to support scientific knowledge exchange and international research partnerships in neuromodulation.
Comments